| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
32,304 |
30,496 |
$975K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
18,386 |
17,353 |
$861K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
17,652 |
16,697 |
$619K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
20,353 |
16,462 |
$414K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
29,388 |
27,995 |
$357K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
5,030 |
4,779 |
$138K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
832 |
775 |
$17K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
223 |
214 |
$10K |
| 87807 |
|
750 |
716 |
$8K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
143 |
141 |
$5K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
119 |
114 |
$5K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
408 |
371 |
$4K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
103 |
96 |
$2K |
| 81000 |
|
722 |
687 |
$1K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
171 |
156 |
$144.60 |
| 82948 |
|
12 |
12 |
$12.58 |